A clinical trial has been carried out comparing ten day courses of oral tetroxoprim, TXP, (100 mg) combined with sulphadiazine, SDZ, (250 mg), one tablet twice daily, with ampicillin, 500 mg four times daily in 60 patients with respiratory tract infections. TXP/SDZ was effective in treatment with an...
No comments yet
Be the first to share your thoughts!